You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

80 Results
Guidelines and Advice
Status: Current
ID: GL 4-1
Version: 2
Jan 2021
Guidelines and Advice
Status: Current
ID: GL 27-2
Version: 2
Feb 2021
Guidelines and Advice
Status: Current
ID: ES 30-1
Mar 2021
Guidelines and Advice
May 2021
Guidelines and Advice
Status: Current
Apr 2021
Guidelines and Advice
Status: Current
ID: GL 2-30B
May 2021
Guidelines and Advice
Status: Current
ID: GL-C50-10
Version: 1
May 2021
Guidelines and Advice
Status: Current
Version: 2
May 2021
Guidelines and Advice
Status: Current
ID: ES 11-13
Feb 2021
Guidelines and Advice
Status: Current
ID: GL-C50-32
Jan 2021
Guidelines and Advice
Status: Current
ID: N/A
Version: 2.1
Sep 2021
Regimen
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant
Drugs Used:
CISplatin,
vinorelbine
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jun 2021

Pages